Literature DB >> 9014841

Specific expression of haptoglobin mRNA in implantation-stage rabbit uterine epithelium.

G E Olson1, V P Winfrey, P E Matrisian, M H Melner, L H Hoffman.   

Abstract

A glycoprotein, termed GP42, was previously identified in uterine fluid obtained from peri-implantation-stage rabbits. N-terminus amino acid sequencing of purified GP42 demonstrated identity through the first 13 amino acids with the beta subunit of liver haptoglobin. The present study was undertaken to determine if GP42 is indeed identical to haptoglobin and, if so, to determine whether it is expressed in the uterus as opposed to being present as a transudate from plasma. Reverse transcription-PCR amplification of poly(A)+ RNA prepared from implantation-stage rabbit endometrium with GP42- and haptoglobin-specific primers yielded a predicted 667 bp cDNA product. Sequence analysis of the cloned cDNA confirmed the identity of GP42 with beta-haptoglobin. Northern blot analysis demonstrated the specific expression of haptoglobin mRNA in the peri-implantation-stage endometrium and the absence of its expression in the estrous or day 4 pseudopregnant endometrium. Non-isotopic in situ hybridization revealed that the haptoglobin mRNA was restricted to the epithelium lining the luminal surface and mucosal folds of day 6(3/4) pregnant or pseudo-pregnant uteri and that no haptoglobin mRNA was detectable in the epithelium of the deep glands or cells of the stroma or myometrium. Similarly, in situ hybridization revealed no expression of haptoglobin mRNA in any cell types of the estrous uterus. These data establish the identity of GP42 with beta-haptoglobin and demonstrate that it is expressed in a stage-specific manner just prior to implantation, correlating with uterine receptivity to blastocyst implantation. Endometrial GP42 mRNA expression is not dependent on the presence of blastocysts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9014841     DOI: 10.1677/joe.0.1520069

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Inflammatory cytokines differentially up-regulate human endometrial haptoglobin production in women with endometriosis.

Authors:  K L Sharpe-Timms; H Nabli; R L Zimmer; J A Birt; J W Davis
Journal:  Hum Reprod       Date:  2010-02-22       Impact factor: 6.918

2.  Evidence of haptoglobin in the porcine female genital tract during oestrous cycle and its effect on in vitro embryo production.

Authors:  Francisco A García-Vázquez; Carla Moros-Nicolás; Rebeca López-Úbeda; Ernesto Rodríguez-Tobón; Ascensión Guillén-Martínez; Jason W Ross; Chiara Luongo; Carmen Matás; Iván Hernández-Caravaca; Manuel Avilés; Mª José Izquierdo-Rico
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

3.  Detection of haptoglobin in seminal plasma of Awassi rams and the relation with its level in serum and some semen parameters.

Authors:  Dhafer M Aziz; Ahmad K Ahmad
Journal:  J Adv Res       Date:  2012-12-04       Impact factor: 10.479

4.  Smoking, haptoglobin and fertility in humans.

Authors:  N Bottini; A Magrini; J Macmurray; E Cosmi; M Nicotra; F Gloria-Bottini; A Bergamaschi
Journal:  Tob Induc Dis       Date:  2002-01-15       Impact factor: 2.600

5.  Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.

Authors:  Olga Lilia Garibay-Cerdenares; Verónica Ivonne Hernández-Ramírez; Juan Carlos Osorio-Trujillo; Magdalena Hernández-Ortíz; Dolores Gallardo-Rincón; David Cantú de León; Sergio Encarnación-Guevara; Julio César Villegas-Pineda; Patricia Talamás-Rohana
Journal:  J Ovarian Res       Date:  2014-02-27       Impact factor: 4.234

6.  A proteomic analysis of the endometrium in obese and overweight women with recurrent miscarriage: preliminary evidence for an endometrial defect.

Authors:  Mostafa Metwally; Rebecca Preece; Jerry Thomas; William Ledger; Tin Chiu Li
Journal:  Reprod Biol Endocrinol       Date:  2014-08-05       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.